乙型肝炎后肝硬化是乙型肝炎逐步进展导致的慢性疾病。近年来,越来越多的研究表明,中医治疗乙肝肝硬化具有独特优势。罗伟生教授治疗乙肝肝硬化运用“肝脾同调”的治疗思路,在临床实践中,采用软坚消癥化瘀法,方选自拟方八珍荔核散结方...乙型肝炎后肝硬化是乙型肝炎逐步进展导致的慢性疾病。近年来,越来越多的研究表明,中医治疗乙肝肝硬化具有独特优势。罗伟生教授治疗乙肝肝硬化运用“肝脾同调”的治疗思路,在临床实践中,采用软坚消癥化瘀法,方选自拟方八珍荔核散结方加减治疗乙型肝炎后肝硬化,疗效可观,能够有效改善乙肝肝硬化患者的症状,降低肝功能指标,延缓病情进展。分享罗伟生教授治疗乙型肝炎后肝硬化(肝郁脾虚,气滞血瘀证)医案1则。Post-hepatitis B cirrhosis is a chronic disease caused by the progressive progression of hepatitis B. In recent years, more and more studies have shown that traditional Chinese medicine has unique advantages in the treatment of hepatitis B cirrhosis. Professor Luo Weisheng uses the therapeutic idea of “the same regulation of liver and spleen” in the treatment of hepatitis B cirrhosis. In clinical practice, he uses the method of resolving hard lump and removing blood stasis, and uses the Bazhen Decoction Combined with Lychee-Nut Formula for the treatment of hepatitis B cirrhosis. The curative effect is considerable, which can effectively improve the symptoms of patients with hepatitis B cirrhosis, reduce liver function indexes, and delay the progress of the disease. Professor Luo Weisheng’s medical case of treating post-hepatitis B cirrhosis (liver stagnation and spleen deficiency, qi stagnation and blood stasis syndrome) is shared.展开更多
文摘乙型肝炎后肝硬化是乙型肝炎逐步进展导致的慢性疾病。近年来,越来越多的研究表明,中医治疗乙肝肝硬化具有独特优势。罗伟生教授治疗乙肝肝硬化运用“肝脾同调”的治疗思路,在临床实践中,采用软坚消癥化瘀法,方选自拟方八珍荔核散结方加减治疗乙型肝炎后肝硬化,疗效可观,能够有效改善乙肝肝硬化患者的症状,降低肝功能指标,延缓病情进展。分享罗伟生教授治疗乙型肝炎后肝硬化(肝郁脾虚,气滞血瘀证)医案1则。Post-hepatitis B cirrhosis is a chronic disease caused by the progressive progression of hepatitis B. In recent years, more and more studies have shown that traditional Chinese medicine has unique advantages in the treatment of hepatitis B cirrhosis. Professor Luo Weisheng uses the therapeutic idea of “the same regulation of liver and spleen” in the treatment of hepatitis B cirrhosis. In clinical practice, he uses the method of resolving hard lump and removing blood stasis, and uses the Bazhen Decoction Combined with Lychee-Nut Formula for the treatment of hepatitis B cirrhosis. The curative effect is considerable, which can effectively improve the symptoms of patients with hepatitis B cirrhosis, reduce liver function indexes, and delay the progress of the disease. Professor Luo Weisheng’s medical case of treating post-hepatitis B cirrhosis (liver stagnation and spleen deficiency, qi stagnation and blood stasis syndrome) is shared.
